Domain binding and isotype dictate the activity of anti-human OX40 antibodies | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Clinical/translational cancer immunotherapy

Original research

Domain binding and isotype dictate the activity of anti-human OX40 antibodies

Online download statistics by month:

Online download statistics by month: December 2020 to May 2023

	Abstract	Full	Pdf
Dec 2020	336	336	62
Jan 2021	526	524	205
Feb 2021	163	163	114
Mar 2021	139	140	86
Apr 2021	61	61	50
May 2021	48	48	62
Jun 2021	95	95	62
Jul 2021	79	79	83
Aug 2021	72	72	50
Sep 2021	89	89	46
Oct 2021	106	106	71
Nov 2021	92	92	64
Dec 2021	71	71	46
Jan 2022	84	92	86
Feb 2022	43	45	18
Mar 2022	97	98	46
Apr 2022	60	69	37
May 2022	59	61	33
Jun 2022	95	112	55
Jul 2022	78	83	45
Aug 2022	89	90	45
Sep 2022	73	74	48
Oct 2022	63	73	39
Nov 2022	69	69	22
Dec 2022	49	49	21
Jan 2023	64	66	30
Feb 2023	91	92	23
Mar 2023	80	83	47
Apr 2023	29	33	23
May 2023	48	50	19
Total	3048	3115	1638